Powered by


                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS







   Forum Archives





















   Primary Care






   Other Sections


   Research Tools

   Medical Tutorials

   Medical Software




Idiopathic thrombocytopenic purpura

Idiopathic thrombocytopenic purpura is also known as immune thrombocytopenic purpura. Idiopathic thrombocytopenic purpura is the condition of having a low platelet count (thrombocytopenia) of no known cause (idiopathic).

Signs and symptoms

Often, low platelet counts are picked up by coincidence when a full blood count has been ordered for routine testing. Occasionally, ITP patients suffer from bruising, nosebleeds, and bleeding gums. This normally does not occur unless the platelet count is very low (10,000 per mm3).

advertisement.gif (61x7 -- 0 bytes)

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


Low platelet count can be a feature of a large number of diseases and, when serious, warrants investigation by a haematology. In many cases, the cause is not really idiopathic but autoimmune, although antibodies against platelets are only detected in a minority.


Mild ITP does not require treatment. When platelet counts fall under 10,000 per milliliter, or under 50,000 when hemorrhage occurs (e.g. in the digestive tract or in a severe nosebleed) treatment is generally initiated with steroids, and later with so-called steroid-sparing agents (alternatively called DMARDs). When these strategies fail, splenectomy (removal of the spleen) is often undertaken, as platelets targeted for destruction will often meet their fate in the spleen. A relatively new strategy is treatment with anti-D, an agent used in mothers who have been sensitised to rhesus antigen by a Rh+ baby. Extreme cases (very rare, especially rare in children) may require vincristine, a chemotherapy agent, to stop the immune system from destroying platelets.

previous.gif (72x17 -- 347 bytes) next.gif (72x17 -- 277 bytes)

 advertisement.gif (61x7 -- 0 bytes)



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright 2001-2012 DoctorsLounge. All rights reserved.